Cardiovascular software developer HeartFlow is highlighting clinical results from studies presented at the recent Society of Cardiovascular CT (SCCT) conference in Boston.
The REVEALPLAQUE study showed that the company's HeartFlow Plaque Analysis demonstrated a 95% agreement with intravascular ultrasound in quantification and characterization of total plaque volume, HeartFlow said.
The DECODE study showed that clinicians who used the HeartFlow Plaque Analysis along with coronary CT angiography changed their management decisions for 66% of patients compared with using CCTA alone across various patient presentations and disease stages, according to the firm.
The SMART-CT study demonstrated that HeartFlow's RoadMap Analysis helped clinicians read cases 25% faster while maintaining diagnostic accuracy, the company said.
